In the meantime, Prostate Cancer Research's report says, screening 45-69-year-olds at high risk - black men and those with a ...

Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access ...

At the same time, aggressive treatment declined in men with low-risk prostate cancer as might have been expected in an era ...

Among patients with average life expectancies of less than 10 years, the proportion who underwent treatments such as surgery ...

Increasing percentages of some older U.S. men with intermediate-risk and high-risk prostate cancers are undergoing treatments ...

Artificial intelligence (AI)-based risk classification improves prognostication with localized prostate cancer, according to ...

“The MMAI risk classifier is a more precise and accurate prognosticator of metastasis than NCCN risk groups,” Dr Tward’s team wrote. “This approach aims to prevent both overtreatment and ...

Increasing percentages of some older U.S. men with intermediate-risk and high-risk prostate cancers are undergoing treatments that carry risks of side effects that can significantly reduce the quality ...

Increasing numbers of older U.S. men with prostate cancer are undergoing treatments that carry risks of side effects that can ...

Scientists uncover functionality of a genetic variant in the prostate specific antigen (PSA) gene to improve the current diagnostic test to help distinguish aggressive from non-aggressive prostate ...